Yuling Wu

1.6k total citations
32 papers, 849 citations indexed

About

Yuling Wu is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yuling Wu has authored 32 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Immunology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yuling Wu's work include Biosimilars and Bioanalytical Methods (10 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Yuling Wu is often cited by papers focused on Biosimilars and Bioanalytical Methods (10 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Yuling Wu collaborates with scholars based in United States, China and Australia. Yuling Wu's co-authors include Hasan S. Jafri, Mark T. Esser, Xiang‐Qing Yu, Terramika Bellamy, Gabriel J. Robbie, Martha Hernandez‐Illas, Lorin Roskos, Li Yu, Kathryn Jensen and Howard I. Schwartz and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Clinical Microbiology.

In The Last Decade

Yuling Wu

30 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuling Wu United States 17 385 303 203 201 129 32 849
Xiang‐Qing Yu United States 16 498 1.3× 179 0.6× 325 1.6× 237 1.2× 109 0.8× 21 980
Mingju Hao China 12 236 0.6× 85 0.3× 141 0.7× 90 0.4× 132 1.0× 33 663
Tillman Pearce United States 13 225 0.6× 176 0.6× 54 0.3× 63 0.3× 225 1.7× 35 789
Blaire L. Osborn United States 14 379 1.0× 129 0.4× 215 1.1× 63 0.3× 130 1.0× 26 830
John G. Chosay United States 12 300 0.8× 285 0.9× 41 0.2× 279 1.4× 95 0.7× 16 934
A. Wunderlich Germany 14 226 0.6× 238 0.8× 99 0.5× 48 0.2× 158 1.2× 21 791
Yan Liang China 19 326 0.8× 368 1.2× 60 0.3× 570 2.8× 124 1.0× 80 1.1k
Hélène Gazzano-Santoro United States 13 685 1.8× 676 2.2× 572 2.8× 43 0.2× 105 0.8× 19 1.3k
Darawan Rinchai United States 21 303 0.8× 274 0.9× 49 0.2× 70 0.3× 113 0.9× 58 928

Countries citing papers authored by Yuling Wu

Since Specialization
Citations

This map shows the geographic impact of Yuling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuling Wu more than expected).

Fields of papers citing papers by Yuling Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuling Wu. The network helps show where Yuling Wu may publish in the future.

Co-authorship network of co-authors of Yuling Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuling Wu. A scholar is included among the top collaborators of Yuling Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuling Wu. Yuling Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yuling, Ayşe Gelal, Chisook Moon, et al.. (2025). Pharmacogenetics of steady-state metabolism, pharmacokinetics, and adverse effects of voriconazole in healthy participants. Drug Metabolism and Disposition. 53(10). 100156–100156.
2.
Suh, Moo‐Jin, Joshua B. Powers, Casey M. Daniels, & Yuling Wu. (2023). Enhanced Pharmacokinetic Bioanalysis of Antibody–drug Conjugates using Hybrid Immunoaffinity Capture and Microflow LC-MS/MS. The AAPS Journal. 25(4). 68–68. 8 indexed citations
3.
Wu, Yuling, Guosheng Liu, Zengpeng Li, Mingliang Chen, & Qin Wang. (2023). ATG13 is involved in immune response of pathogen invasion in blood clam Tegillarca granosa. Frontiers in Veterinary Science. 10. 1141284–1141284. 1 indexed citations
4.
Chen, Yi, Yuling Wu, Cai–Yang Chen, et al.. (2022). METTL3-Mediated N6-Methyladenosine Modification of Trim59 mRNA Protects Against Sepsis-Induced Acute Respiratory Distress Syndrome. Frontiers in Immunology. 13. 897487–897487. 31 indexed citations
5.
Lü, Qiang, et al.. (2021). Therapeutic Efficacy and Safety of Safflower Injection in the Treatment of Acute Coronary Syndrome. Evidence-based Complementary and Alternative Medicine. 2021. 1–10. 6 indexed citations
6.
Liu, Guifeng, Ying Bao, Xi Zhang, et al.. (2021). Prognostic Factors of Colorectal Cancer: A Comparative Study on Patients With or Without Liver Metastasis. Frontiers in Oncology. 11. 626190–626190. 7 indexed citations
7.
Li, Cailan, et al.. (2020). The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease. Evidence-based Complementary and Alternative Medicine. 2020(1). 5067137–5067137. 14 indexed citations
8.
Duan, Jingxian, Yuling Wu, Jikui Liu, et al.. (2019). <p>Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine</p>. Journal of Hepatocellular Carcinoma. Volume 6. 151–166. 27 indexed citations
9.
Kijanka, Grzegorz, Jared S. Bee, Mark A. Schenerman, et al.. (2019). Monoclonal Antibody Dimers Induced by Low pH, Heat, or Light Exposure Are Not Immunogenic Upon Subcutaneous Administration in a Mouse Model. Journal of Pharmaceutical Sciences. 109(1). 730–738. 12 indexed citations
10.
Kijanka, Grzegorz, Jared S. Bee, Yuling Wu, et al.. (2018). Submicron Size Particles of a Murine Monoclonal Antibody Are More Immunogenic Than Soluble Oligomers or Micron Size Particles Upon Subcutaneous Administration in Mice. Journal of Pharmaceutical Sciences. 107(11). 2847–2859. 56 indexed citations
11.
12.
Ali, Omar, Xiang‐Qing Yu, Gabriel J. Robbie, et al.. (2018). Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults. Clinical Microbiology and Infection. 25(5). 629.e1–629.e6. 92 indexed citations
13.
14.
Zhong, Zhandong Don, Adrienne Clements‐Egan, Boris Gorovits, et al.. (2017). Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation Strategies. The AAPS Journal. 19(6). 1564–1575. 43 indexed citations
15.
Gallagher, Sandra, Isharat Yusuf, Yuling Wu, et al.. (2016). Pharmacological profile of MEDI-551, a novel anti-CD19 antibody, in human CD19 transgenic mice. International Immunopharmacology. 36. 205–212. 12 indexed citations
16.
Wu, Yuling, Hyun‐Jun Kim, Xu Liu, et al.. (2015). A Neutralizing Antibody Assay Based on a Reporter of Antibody-Dependent Cell-Mediated Cytotoxicity. The AAPS Journal. 17(6). 1417–1426. 11 indexed citations
17.
Wu, Yuling, Xu Liu, Yan Chen, et al.. (2013). An electrochemiluminescence (ECL)-based assay for the specific detection of anti-drug antibodies of the IgE isotype. Journal of Pharmaceutical and Biomedical Analysis. 86. 73–81. 14 indexed citations
18.
Chen, Hong, et al.. (2012). The clinical efficacy of Danhong injections for unstable angina. Guoji yiyao weisheng daobao. 18(19). 2883–2885. 1 indexed citations
19.
Kubiak, Robert, Lanju Zhang, Jianchun Zhang, et al.. (2012). Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assays. Journal of Pharmaceutical and Biomedical Analysis. 74. 235–245. 16 indexed citations
20.
Xiao, Jim, Wojciech Krzyżański, Yow‐Ming Wang, et al.. (2010). Pharmacokinetics of Anti-hepcidin Monoclonal Antibody Ab 12B9m and Hepcidin in Cynomolgus Monkeys. The AAPS Journal. 12(4). 646–657. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiang‐Qing Yu Breakdown of academic impact, for papers by Mingju Hao Breakdown of academic impact, for papers by Tillman Pearce Breakdown of academic impact, for papers by Blaire L. Osborn Breakdown of academic impact, for papers by John G. Chosay Breakdown of academic impact, for papers by A. Wunderlich Breakdown of academic impact, for papers by Yan Liang Breakdown of academic impact, for papers by Hélène Gazzano-Santoro Breakdown of academic impact, for papers by Darawan Rinchai
Rankless by CCL
2026